Research location
Lund
Sweden
Research activity in Lund
SwedenCureCurrent currently publishes aggregate city-level research activity for this location: 481 trials and 502 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Lund
481 linked trials · page 1 of 10A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes MellitusNCT07776509 · 2026-08-24 · 1 site observation
RECRUITING
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFNCT07761117 · 2026-08-24 · 1 site observation
RECRUITING
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body WeightNCT07745504 · 2026-08-04 · 1 site observation
RECRUITING
A 12-Week Study of Flexilev With the OraFID Device and App in Parkinson's PatientsNCT07839793 · 2026-05-25 · 1 site observation
RECRUITING
Efficacy of L-menthol on Breathlessness in AsthmaNCT07500974 · 2026-05-07 · 1 site observation
RECRUITING
Non-Invasive Hemodynamic Monitoring in Hospitalized Heart FailureNCT07671742 · 2026-04-01 · 1 site observation
RECRUITING
Selenium Intervention Registry Randomized Trial in Heart FailureNCT07543562 · 2026-04-01 · 1 site observation
RECRUITING
Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac SurgeryNCT07351149 · 2026-03-01 · 1 site observation
RECRUITING
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)NCT07222332 · 2026-02-05 · 1 site observation
RECRUITING
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.NCT07053423 · 2025-09-22 · 1 site observation
RECRUITING
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesityNCT07037433 · 2025-07-25 · 1 site observation
RECRUITING
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityNCT07037459 · 2025-06-25 · 1 site observation
RECRUITING
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 InflammationNCT06959095 · 2025-06-20 · 1 site observation
RECRUITING
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)NCT06966401 · 2025-04-16 · 1 site observation
RECRUITING
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial CancerNCT06989112 · 2025-03-27 · 1 site observation
RECRUITING
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)NCT06878261 · 2025-03-25 · 1 site observation
RECRUITING
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinNCT06677060 · 2025-03-14 · 2 site observations
RECRUITING
REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve FailureNCT06557798 · 2024-12-12 · 1 site observation
RECRUITING
Probiotic Supplementation During Pregnancy in Women With High-Risk PregnanciesNCT06700044 · 2024-12-10 · 1 site observation
RECRUITING
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)NCT06452277 · 2024-08-28 · 1 site observation
RECRUITING
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia SymptomsNCT06559306 · 2024-07-25 · 1 site observation
RECRUITING
Mediastinal EBUS Cryobiopsy Study In SwedenNCT06347939 · 2024-04-01 · 1 site observation
RECRUITING
AI-based Measurements of Tumour Burden in PSMA PET-CTNCT06363435 · 2024-03-29 · 1 site observation
RECRUITING
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseaseNCT06283966 · 2024-02-21 · 1 site observation
RECRUITING
PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm PreeclampsiaNCT06033131 · 2024-01-19 · 1 site observation
RECRUITING
Gestational Diabetes After Gastric Bypass SurgeryNCT06291766 · 2024-01-01 · 1 site observation
RECRUITING
Improving CRT Outcome With Non-Invasive Cardiac MappingNCT05564793 · 2023-12-20 · 1 site observation
RECRUITING
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)NCT05512364 · 2023-12-15 · 1 site observation
RECRUITING
Addition of Hypofractionated High Dose Radiation in Oligometastatic DiseaseNCT06141070 · 2023-12-01 · 1 site observation
RECRUITING
Tumor-directed Radiation Therapy for Patients With the Highest Risk Category of Localized Prostate CancerNCT06220435 · 2023-09-25 · 1 site observation
RECRUITING
Use of GnRHa During Chemotherapy for Fertility ProtectionNCT05328258 · 2023-03-31 · 3 site observations
RECRUITING
The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases.NCT05634889 · 2023-03-17 · 1 site observation
RECRUITING
EGFR-mutated Lung Cancer in Randomized Investigator-Initiated StudyNCT06486142 · 2022-09-21 · 1 site observation
RECRUITING
Tissue Regeneration in Patients With Chronic Obstructive Pulmonary Disease After an Exercise Intervention.NCT06335992 · 2022-09-01 · 1 site observation
RECRUITING
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid MalignanciesNCT05417594 · 2022-06-24 · 1 site observation
RECRUITING
MYTHS - MYocarditis THerapy With SteroidsNCT05150704 · 2021-10-07 · 1 site observation
RECRUITING
Personalized Radiotherapy for Biochemical Recurrence of Prostate Cancer After Prostatectomy.NCT04858880 · 2021-04-09 · 1 site observation
RECRUITING
Sweden Cancerome Analysis Network - Breast Recurrence (SCAN-B-rec)NCT03758976 · 2019-01-21 · 2 site observations
RECRUITING
Partial Breast Versus no Irradiation for Women With Early Breast CancerNCT03646955 · 2018-09-05 · 1 site observation
RECRUITING
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection FractionNCT02901184 · 2017-11-23 · 3 site observations
RECRUITING
Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast CancerNCT02306096 · 2010-08-01 · 1 site observation
RECRUITING
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsNCT00271180 · 1983-01-01 · 1 site observation
RECRUITING
Simplified Exercise-based Risk Assessment in Lung CancerNCT07506889 · 2026-04-01 · 1 site observation
NOT_YET_RECRUITING
COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)NCT07455097 · 2026-01-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast CancerNCT06223698 · 2025-05-02 · 1 site observation
NOT_YET_RECRUITING
A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast CancerNCT02958852 · 2025-01-02 · 1 site observation
COMPLETED
Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)NCT06691984 · 2024-12-09 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)NCT06660173 · 2024-11-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk AsthmaNCT06676319 · 2024-11-07 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and Long-term Extension Treatment With AticaprantNCT06514742 · 2024-06-26 · 1 site observation
TERMINATED
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.